Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against LifeStance Health Group (“LifeStance” or the “Company”) (NASDAQ: LFST) on behalf of LifeStance stockholders. Our investigation concerns whether LifeStance has violated the federal securities laws and/or engaged in other unlawful business practices.

Click here to participate in the action.

LifeStance is one of the nation’s largest providers of virtual and in-person outpatient mental health care for children, adolescents and adults experiencing a variety of mental health conditions.

On August 11, 2021, LifeStance announced financial results for the second quarter ended June 30, 2021. The company reported a $70 million net loss in the second quarter and issued third quarter guidance that missed estimates as healthcare companies struggle to retain physicians suffering burnout by the COVID-19 pandemic.

On this news, LifeStance’s stock price fell $10.16 per share, to close at $11.71 per share August 12, 2021.

If you purchased or otherwise acquired LifeStance shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Alexandra Raymond by email at investigations@bespc.com, telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211117006444/en/